ATS 2024 Final Program

Click on the session title to view the speakers

249

TUESDAY • MAY 21

P1219 A Randomized, Double-Blind, Placebo-Controlled Phase1 Single and Multiple-Dose Pharmacokinetic First-In-Human Study of AV-001 in Healthy Subjects for the Treatment of Acute Respiratory Distress Syndrome P1220 Vilobelimab in Combination With Tocilizumab or Baricitinib Dramatically Improves Mortality in Critically Ill COVID-19 Patients: A Subgroup Analysis P1221 Real-time Prospective Classification of Biologic Sub-phenotypes in Severe Acute Respiratory Failure: An Interim Report on the SPARC Study P1222 The Association of Circulating Renin Angiotensin System Components With Clinical Outcomes and Treatment Responses in COVID-19: A Mechanistic Substudy of the ACTIV-4 Host Tissue Trials P1223 Translating Cis-regulatory Elements Activity With Traditional Transcriptomic Using Machine Learning - Implication on Profiling Transcription Factor Activity for ARDS Endotyping C41 PUMP YOU UP - ECMO AND CARDIAC DEVICE OPTIMIZATION 9:15 a.m. - 4:15 p.m. San Diego Convention Center Area K (Hall H, Ground Level) Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P1225 Comparison of Anticoagulation Goals in Patients With COVID-19 ARDS Supported With VV-ECMO P1226 Ventilator and Pulmonary Physiology Parameters Prior to Extracorporeal Membrane Oxygenation (ECMO) Cannulation Do Not Predict Pulmonary Functional Recovery in Survivors of Severe Acute Respiratory Distress Syndrome (ARDS) P1227 Online Patient Information on Extracorporeal Membrane Oxygenation: An Assessment of Readability BEHAVIORAL • CLINICAL THEMATIC POSTER SESSION

P1228 Impact of Obesity on Extracorporeal Membrane Oxygenation in ARDS P1229 Clinical Outcomes in Octogenarians, Nonagenarians, and Centenarians Who Underwent Veno-arterial Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study P1230 Outcomes of Extracorporeal Membrane Oxygen (ECMO) Therapy and Acute Respiratory Distress Syndrome (ARDS) Severity at Time of Cannulation in Those With and Without COVID-19 Infection - A Single Center Retrospective Study P1231 Trends and Outcomes of ECMO Support Before and After the COVID-19 Outbreak: A Nationwide Study P1232 Cost Comparison of Veno-venous (VV) Extracorporeal Membrane Oxygenation (ECMO) Between Patients With COVID-19 and Non-pandemic Patients: A Binational Prospective Observational Clinical Registry Analysis P1233 Extracorporeal Membrane Oxygenation (ECMO) and Continuous Renal Replacement Therapy (CRRT): A Descriptive Review of Observations P1234 Frequency of Oxygenator Change in Extracorporeal Membrane Oxygenation (ECMO) - An Institutional Review of VV and VA ECMO Case Cohort P1235 Clinical Outcomes for Patients With Left Bundle Branch Block (LBBB) Who UnderwentVenoarterial Extracorporeal Membrane Oxygenation (VA-ECMO): An Analysis of the National Inpatient Sample P1236 Sex Differences in Outcomes Among Patients Undergoing IABP Procedure: A Retrospective Cohort Study P1237 Clinical Outcomes for Intra-aortic Balloon Pump in Octogenarians, Nonagenarians, and Centenarians: A Retrospective Cohort Study P1238 Clinical Outcomes for Patients With Ventricular Tachycardia Who Underwent Intra-Aortic Balloon Pump: An Analysis of the National Inpatient Sample P1239 Adverse Events Related to Impella CP and Impella 5.5 from the Manufacturer and User Facility Device Experience Database P1240 Influence of Gender in LVAD-Associated Complications: 30- and 60-day Readmission and Discharge to Hospice

ATS 2024 Conference Program • San Diego, CA